Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 2
1963 2
1964 3
1966 1
1967 2
1968 5
1969 3
1970 3
1972 3
1973 3
1974 5
1975 1
1976 2
1977 3
1979 5
1980 4
1981 3
1982 6
1983 10
1984 5
1985 5
1986 7
1987 9
1988 11
1989 4
1990 11
1991 10
1992 4
1993 3
1994 5
1995 5
1996 5
1997 7
1998 6
1999 7
2000 8
2001 6
2002 3
2003 8
2004 3
2005 4
2006 8
2007 6
2008 7
2009 4
2010 8
2011 6
2012 6
2013 2
2014 11
2015 15
2016 14
2017 22
2018 21
2019 15
2020 11
2021 17
2022 25
2023 15
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

382 results

Results by year

Filters applied: . Clear all
Page 1
The hepatic niche leads to aggressive natural killer cell leukemia proliferation through the transferrin-transferrin receptor 1 axis.
Kameda K, Yanagiya R, Miyatake Y, Carreras J, Higuchi H, Murayama H, Ishida T, Ito A, Iida S, Fukuhara N, Harigae H, Fujioka Y, Takahashi N, Wada H, Ishida F, Nakazawa H, Ishihara R, Murakami Y, Tagawa H, Matsuura T, Nakagawa S, Iwabuchi S, Hashimoto S, Imadome KI, Nakamura N, Ishizawa K, Kanda Y, Ando K, Kotani A. Kameda K, et al. Blood. 2023 Jul 27;142(4):352-364. doi: 10.1182/blood.2022018597. Blood. 2023. PMID: 37146246
Autologous or allogeneic hematopoietic cell transplantation for relapsed or refractory PTCL-NOS or AITL.
Kameda K, Kako S, Kim SW, Usui Y, Kato K, Fukuda T, Uchida N, Kobayashi H, Wakayama T, Sakaida E, Yano S, Imada K, Nara M, Ikeda T, Fuchida SI, Ishikawa J, Sugahara H, Kanda J, Kimura T, Ichinohe T, Atsuta Y, Kondo E. Kameda K, et al. Leukemia. 2022 May;36(5):1361-1370. doi: 10.1038/s41375-022-01545-w. Epub 2022 Mar 28. Leukemia. 2022. PMID: 35347237
Innovation in diagnostics: addressing gaps in low- and middle-income countries.
Chamas C, Barbeitas MM, Correa M, Kameda K, de Oliveira ACD, Villarinho L. Chamas C, et al. Among authors: kameda k. Bull World Health Organ. 2022 Aug 1;100(8):467-467A. doi: 10.2471/BLT.22.288313. Bull World Health Organ. 2022. PMID: 35923283 Free PMC article. No abstract available.
Low-Intensity Immunosuppressive Therapy for Chronic Graft-versus-Host Disease.
Yoshimura K, Kimura SI, Nakasone H, Nakamura Y, Kawamura M, Kawamura S, Takeshita J, Yoshino N, Misaki Y, Matsumi S, Gomyo A, Tanihara A, Okada Y, Tamaki M, Kusuda M, Kameda K, Wada H, Kako S, Kanda Y. Yoshimura K, et al. Among authors: kameda k. Transplant Cell Ther. 2022 Sep;28(9):597.e1-597.e9. doi: 10.1016/j.jtct.2022.06.014. Epub 2022 Jun 22. Transplant Cell Ther. 2022. PMID: 35750283 Free article.
Reduced-HMGB1 suppresses poly(I:C)-induced inflammation in keratinocytes.
Mori H, Murakami M, Tsuda T, Kameda K, Utsunomiya R, Masuda K, Shiraishi K, Dai X, Tohyama M, Nakaoka H, Sayama K. Mori H, et al. Among authors: kameda k. J Dermatol Sci. 2018 May;90(2):154-165. doi: 10.1016/j.jdermsci.2018.01.007. Epub 2018 Feb 2. J Dermatol Sci. 2018. PMID: 29395576
Adverse Events Associated With Infusion of Hematopoietic Stem Cell Products: A Prospective and Multicenter Surveillance Study.
Ikeda K, Ohto H, Okuyama Y, Yamada-Fujiwara M, Kanamori H, Fujiwara SI, Muroi K, Mori T, Kasama K, Iseki T, Nagamura-Inoue T, Fujii N, Ashida T, Kameda K, Kanda J, Hirose A, Takahashi T, Nagai K, Minakawa K, Tanosaki R. Ikeda K, et al. Among authors: kameda k. Transfus Med Rev. 2018 Jun 1:S0887-7963(18)30023-3. doi: 10.1016/j.tmrv.2018.05.005. Online ahead of print. Transfus Med Rev. 2018. PMID: 29891441 Free article. Review.
Comparison of cryoprotectants in hematopoietic cell infusion-related adverse events.
Ikeda K, Minakawa K, Yamahara K, Yamada-Fujiwara M, Okuyama Y, Fujiwara SI, Yamazaki R, Kanamori H, Iseki T, Nagamura-Inoue T, Kameda K, Nagai K, Fujii N, Ashida T, Hirose A, Takahashi T, Ohto H, Ueda K, Tanosaki R. Ikeda K, et al. Among authors: kameda k. Transfusion. 2022 Jun;62(6):1280-1288. doi: 10.1111/trf.16877. Epub 2022 Apr 9. Transfusion. 2022. PMID: 35396716
382 results